OPIOIDS AND HORMONAL METABOLIC ABNORMALITIES IN POLYCYSTIC OVARIAN DISEASE (HUMAN

阿片类药物与多囊卵巢病（人类）中的激素代谢异常

• 批准号: 3926854
• 负责人: FOUAD R KANDEEL
• 金额: --
• 依托单位: LOS ANGELES COUNTY HARBOR-UCLA MED CTR
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3926854
• 关键词: endorphins; gonadotropin releasing factor; human subject; human therapy evaluation; metabolism disorder; naloxone; polycystic ovary syndrome; progesterone; weight control

Whether endogenous opioid is a major mechanism for metabolic abnormalities seen in polycystic ovarian disease will be studied. Hormonal and metabolic responses in patients with PCOD will be studied before and after anti-narcotic, anti-opioid treatment. These changes will be compared to those seen in patients treated with weight reduction diets.

内源性阿片类药物是否是代谢的主要机制 将研究多囊卵巢疾病中出现的异常。 PCOD 患者的激素和代谢反应将 在抗麻醉、抗阿片类药物治疗之前和之后进行了研究。 这些变化将与接受治疗的患者中观察到的变化进行比较 与减肥饮食。